Simris
Business Services · Sweden · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Herrestadsvägen 24a, Hammenhog, Skane, 2...Phone Number
+46 767888212Website
www.simris.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Simris
Simris Group is a pioneering company in algae biotechnology, focusing on the development of next-generation antibody drug conjugate (ADC) payloads aimed at revolutionizing cancer treatment. Leveraging the world's largest cyanobacterial strain library and extensive scientific expertise, they create novel, IP-protected payloads that enhance the efficacy and safety of ADC therapeutics. Their subsidiary, Simris Biologics, specializes in ADC payloads engineered from cyanobacterial toxins, designed to surpass traditional options in potency, safety, and selectivity. The company targets clients in the biopharmaceutical sector, particularly those involved in cancer therapeutics.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Simris your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Simris recently announced quarterly report
Click to see if Simris had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Simris launches new products
Check out if Simris is spiking on competitors!
Funding: Get notified immidiatlly once Simris has new funding data
Congratulate Masked Content for being promoted to Masked Content at Simris
Check if Simris has recently received funding, and reach out quickly before it becomes old news!
Simris, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Simris as Masked Content
Find 2 more new buyers
Compare Similar Companies to Simris
Compare insights from companies similar to Simris, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Simris
<$5M
1-10
Private
-
2019
N/A
Company Profile Activity
Activity Insights
Simris is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Simris is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Simris.
Simris Tech Stack
A closer look at the technologies used by Simris
Simris News & Media
Simris Alg interim report January-March 2022
Q1, JANUARY–MARCH 2022 · Net revenue was 3 206 (492) kkr of which US was 275 (308) kkr. · Operating result was -4 144 (-7 462) kkr. KEY EVENTS IN Q1 · The Board convened an Extraordinary General Meeting to carry out a rights issue of approximately 25.1 mkr, a directed set-off issue and the issuance of warrants. · Two orders were received for biomass of microalgae totaling 3.0 mkr. They were delivered during theSimris Alg Management Update
Simris Alg AB (publ) (FNSE: SIMRIS) (“Simris” or “Company”) advises that Fredrika Gullfot has tendered her resignation as CEO of the Company. Chairman Steven Schapera will move into an interim executive role whilst the Board commences their search for a new CEO. Fredrika Gullfot, who holds a PhD in engineering in biotechnology from KTH Royal Institute of Technology in Stockholm, founded Simris Alg in 2011 and is globally recognized as a pioneer in microalgae technology.Simris Alg interim report January - March 2021
INCREASED ACTIVITIES IN NEW BUSINESS VERTICALS, NEW E-COMMERCE PLATFORM LAUNCHED Simris Alg AB (publ) (FNSE:SIMRIS) has published its financial results for January – March 2021. MSEK Jan-Mar 2021 Jan-Mar 2020 Jan-Dec 2020 Net sales 0.492 0.265 2.166 Operating results -7.462 -6.859 -23.694 Earnings before tax -6.853 -6.486 -25.537 Net cash from operating activities -7.478 -5.980 -19.485 Cash at end of periodSimris Alg signs agreement on research collaboration
Simris Alg AB (publ) has entered a five-year agreement with Anhalt University of Applied Sciences in Germany (AUAS) for the development of novel biologically active substances from microalgae for advanced skincare. The research on microalgae at AUAS is led by Prof. Dr. Claudia Grewe, who has over ten years of industry experience from leadership positions in research, development and production. The collaboration increases Simris Alg's R&D capacity and aims to accelerate product development withi
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Simris
Sign Up For FreeTo access detailed company insights
Simris Group is a pioneering company in algae biotechnology, focusing on the development of next-generation antibody drug conjugate (ADC) payloads aimed at revolutionizing cancer treatment. Leveraging the world's largest cyanobacterial strain library and extensive scientific expertise, they create novel, IP-protected payloads that enhance the effic... Read More
